Skip to main content
. 2020 Sep 2;11:540187. doi: 10.3389/fphar.2020.540187

Table 4.

Interventional clinical studies for COVID-19.

Interventions Trials Number Percentage
Total 943 100%
Hydroxychloroquine 157 16.6%
Hydroxychloroquine & Azithromycin 51 5.4%
Chloroquine 22 2.3%
Remdesivir 10 1.1%
Lopinavir/Ritonavir 32 3.4%
Favipiravir 16 1.7%
Interferon 23 2.4%
Glucocorticoid 29 3.1%
Immunity therapy 53 5.6%
Targeted Therapy 23 2.4%
Convalescent plasma 66 7.0%
Dietary Supplement 18 1.9%
Device 63 6.7%
Behavioral 47 5.0%
Other 333 35.3%